About Invivyd, Inc. 
Invivyd, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 24 Schemes (12.97%)
Foreign Institutions
Held by 43 Foreign Institutions (2.87%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
17 Million
(Quarterly Results - Dec 2025)
Net Profit:
-11 Million
Pharmaceuticals & Biotechnology
USD 472 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.90
-64.32%
5.07






